美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Americann Inc.

0.0001

0.0000

成交量：64.00

成交額：0.01

市值：2,439.20

市盈率：0.00

高：0.0001

開：0.0001

低：0.0001

收：0.0001

52周最高：0.1201

52周最低：0.0000

股本：2,439.20萬

流通股本：1,373.84萬

量比：0.08

換手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):-0.0976

每股收益(LYR):-0.0514

淨資產收益率：-54.80%

總資產收益率：-5.74%

市淨率：0.00

市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告

BioMarin暫停骨骼疾病療法的中期臨床試驗

环球市场播报

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ACAN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ACAN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACAN\",,,,,undefined,":{"symbol":"ACAN","market":"US","secType":"STK","nameCN":"Americann Inc.","latestPrice":0.0001,"timestamp":1773843474527,"preClose":0.0001,"halted":0,"volume":64,"delay":15,"changeRate":0,"floatShares":13738420,"shares":24391961,"eps":-0.097615,"marketStatus":"未開盤","change":0,"latestTime":"03-18 10:17:54 EDT 延時","open":0.0001,"high":0.0001,"low":0.0001,"amount":0.0064,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.097615,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773907200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.0001,"volumeRatio":0.077992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACAN\",,,,,undefined,":{"symbol":"ACAN","floatShares":13738420,"roa":"-5.74%","roe":"-54.80%","lyrEps":-0.051423,"volumeRatio":0.077992,"shares":24391961,"dividePrice":0,"high":0.0001,"amplitude":0,"preClose":0.0001,"low":0.0001,"week52Low":0.000001,"pbRate":"0.00","psRate":"0.00","week52High":0.12005,"institutionHeld":0,"latestPrice":0.0001,"eps":-0.097615,"divideRate":0,"volume":64,"delay":15,"ttmEps":-0.097615,"open":0.0001,"prevYearClose":0.0001,"prevWeekClose":0.0001,"prevMonthClose":0.0002,"prevQuarterClose":0.0001,"fiveDayClose":0.0001,"twentyDayClose":0.0001,"sixtyDayClose":0.0001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACAN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-14","symbol":"ACAN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-14","symbol":"ACAN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1707886800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-12-22","symbol":"ACAN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1703221200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-14","symbol":"ACAN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1691985600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-02-16","symbol":"ACAN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1676523600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACAN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACAN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACAN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2619464520","title":"BioMarin暫停骨骼疾病療法的中期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2619464520","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619464520?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 22:42","pubTimestamp":1773672120,"startTime":"0","endTime":"0","summary":"BioMarin 制药公司周一宣布，在报告多例患者髋关节脱位事件后，将终止一款骨骼疾病疗法的中期临床试验，消息导致其股价下跌 4%。BioMarin 当时正在对其药物 Voxzogo 进行临床试验，用于治疗特纳综合征、SHOX 基因缺陷及聚集蛋白聚糖缺陷患者。BioMarin 表示，将继续在努南综合征患者及一类原因不明的身材矮小患者中测试该药物。上月，FDA 批准了 Ascendis 制药公司的每周一次注射剂 Yuviwel，使其成为第二款在美国获批用于软骨发育不全的疗法。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-16/doc-inhrezkk2594890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ACAN","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}